Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer
E Picard, CP Verschoor, GW Ma… - Frontiers in …, 2020 - frontiersin.org
Colorectal cancer (CRC) is highly heterogeneous at the genetic and molecular level, which
has major repercussions on the efficacy of immunotherapy. A small subset of CRCs exhibit …
has major repercussions on the efficacy of immunotherapy. A small subset of CRCs exhibit …
The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis
Simple Summary Colorectal cancer (CRC) is the third most common cancer worldwide.
Metastasis to secondary organs, such as the liver and lungs, is a key driver of CRC-related …
Metastasis to secondary organs, such as the liver and lungs, is a key driver of CRC-related …
Cyclooxygenases and prostaglandins in tumor immunology and microenvironment of gastrointestinal cancer
D Wang, CS Cabalag, NJ Clemons, RN DuBois - Gastroenterology, 2021 - Elsevier
Chronic inflammation is a known risk factor for gastrointestinal cancer. The evidence that
nonsteroidal anti-inflammatory drugs suppress the incidence, growth, and metastasis of …
nonsteroidal anti-inflammatory drugs suppress the incidence, growth, and metastasis of …
[HTML][HTML] Fusobacterium nucleatum and colorectal cancer: A review
FM Shang, HL Liu - World journal of gastrointestinal oncology, 2018 - ncbi.nlm.nih.gov
Fusobacterium nucleatum (F. nucleatum) is a Gram-negative obligate anaerobe bacterium
in the oral cavity and plays a role in several oral diseases, including periodontitis and …
in the oral cavity and plays a role in several oral diseases, including periodontitis and …
Determinants of metastatic competency in colorectal cancer
Colorectal cancer (CRC) is one of the most common cancer types and represents a major
therapeutic challenge. Although initial events in colorectal carcinogenesis are relatively well …
therapeutic challenge. Although initial events in colorectal carcinogenesis are relatively well …
Dendritic cells in the tumor microenvironment: prognostic and theranostic impact
J Verneau, C Sautés-Fridman, CM Sun - Seminars in immunology, 2020 - Elsevier
Among all immune cells, dendritic cells (DC) are the most potent APCs in the immune
system and are central players of the adaptive immune response. There are phenotypically …
system and are central players of the adaptive immune response. There are phenotypically …
[HTML][HTML] Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer
M Kießler, I Plesca, U Sommer, R Wehner… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Plasmacytoid dendritic cells (pDCs) play a key role in the induction and
maintenance of antitumor immunity. Conversely, they can act as tolerogenic DCs by …
maintenance of antitumor immunity. Conversely, they can act as tolerogenic DCs by …
Immune contexture, immunoscore, and malignant cell molecular subgroups for prognostic and theranostic classifications of cancers
E Becht, NA Giraldo, C Germain, A de Reyniès… - Advances in …, 2016 - Elsevier
The outcome of tumors results from genetic and epigenetic modifications of the transformed
cells and also from the interactions of the malignant cells with their tumor microenvironment …
cells and also from the interactions of the malignant cells with their tumor microenvironment …
Role of prostanoids in gastrointestinal cancer
D Wang, RN DuBois - The Journal of clinical investigation, 2018 - Am Soc Clin Investig
Chronic inflammation is a risk factor for gastrointestinal cancer and other diseases. Most
studies have focused on cytokines and chemokines as mediators connecting chronic …
studies have focused on cytokines and chemokines as mediators connecting chronic …
Trial watch: Prognostic and predictive value of the immune infiltrate in cancer
L Senovilla, E Vacchelli, J Galon, S Adjemian… - …, 2012 - Taylor & Francis
Solid tumors are constituted of a variety of cellular components, including bona fide
malignant cells as well as endothelial, structural and immune cells. On one hand, the tumor …
malignant cells as well as endothelial, structural and immune cells. On one hand, the tumor …